Partially covered self-expanding metal stent for unresectable malignant extrahepatic biliary obstruction: results of a large prospective series

Gómez-Oliva, Cristina; Guarner-Argente, Carlos; Concepción, Mar; Jiménez, Francisco Javier; Rodríguez, S.; González-Húix, Ferrán; Múgica, Fernando; Cabriada, José Luis; Rodríguez, Claudio; Aguilar, Carlos Guarner

doi:10.1007/s00464-011-1858-z

Cited by 18 publications

(5 citation statements)

References 22 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Median stent patency for partially covered self-expanding metal stents in another study of patients with unresectable malignant extrahepatic biliary obstruction was reported at 138.9 days (18); an additional study evaluated stent patency with covered (mean patency, 225 days) and uncovered (mean patency, 193 days) stents (19). It should be noted, however, that the mean survival for these studies was higher compared to our study, at 141.7 days and 255/237 (covered/uncovered) days, respectively.…”

Section: Discussionmentioning

confidence: 99%

A prospective, multicenter study of a double stent system for palliative treatment of malignant extrahepatic biliary obstructions

et al. 2015

View full text Add to dashboard Cite

show abstract

Section: Discussionmentioning

confidence: 99%

A prospective, multicenter study of a double stent system for palliative treatment of malignant extrahepatic biliary obstructions

et al. 2015

View full text Add to dashboard Cite

show abstract

“…Mortality was 2%, similar to other studies. This paper demystifies some complications that may raise doubts on the usefulness of metallic coated stents in clinical practice, and demonstrates their high effectiveness and safety (24).…”

Section: Coated Metallic Versus Uncoated Metallic Stentsmentioning

confidence: 88%

Endoscopic management of malignant biliary stenosis. Update and highlights for standard clinical practice

Mj¹,

Ma²

2016

Rev Esp Enferm Dig

View full text Add to dashboard Cite

The present review describes the various indications of biliary stent placement in patients with biliary malignancies. It deals in depth with biliary accesses and their effectiveness, as well as with the use of different stents according to lesion type and expected patient survival. For liver hilum lesions, which are somewhat more complex, the usefulness of and need for unilateral or bilateral drainage is assessed, as it is the most appropriate method. All in all, this is an up-to-date literature review that may help clinicians in their daily decision-making, as well as to improve and optimize patient outcomes.

show abstract

“…There are three important limitations to this study. Partially covered stents that do not cause obstruction of the pancreatic duct opening have also recently been used (Gómez-Oliva et al 2012). Use of these stents may achieve long-term patency with fewer complications.…”

Section: Discussionmentioning

confidence: 99%

Percutaneous transhepatic hybrid biliary endoprostheses using both plastic and metallic stents for palliative treatment of malignant common bile duct obstruction

Fujita

Tanabe

Takahashi

et al. 2013

Eur J Cancer Care (Engl)

View full text Add to dashboard Cite

To evaluate clinical safety and efficacy of percutaneous transhepatic hybrid biliary prostheses for palliative treatment in patients with common bile duct obstruction caused by advanced malignancies. A total of 13 consecutive patients was treated with percutaneous transhepatic biliary endoprostheses concurrently using both plastic and metallic stents. Serum total bilirubin levels before and after stent placement were evaluated. The technical success rate, the period with no obstructive jaundice, patient survival and complications were also assessed. Median bilirubin levels decreased from 3.8 mg/dL before to 1.2 mg/dL after stent placement, and this difference was statistically significant. The median no-jaundice period after bile duct stent placement was 6.0 months (range: 2-11 months), and overall survival time was 7.0 months. Of the 13 patients, nine did not have recurrent jaundice by the time of death, whereas four (31%) had recurrent jaundice. A second intervention was performed in these four patients. A new plastic stent was placed and jaundice did not recur up to the time of death. No serious complications such as cholangitis, pancreatitis or bile duct perforation developed. Percutaneous transhepatic hybrid biliary endoprostheses using both plastic and metallic stents can be useful as non-invasive palliative treatment to relieve jaundice in patients with malignant obstructive jaundice.

show abstract

Partially covered self-expanding metal stent for unresectable malignant extrahepatic biliary obstruction: results of a large prospective series

Abstract: The partially covered SEMS was easily inserted, had a high clinical success rate, and prevented tumor ingrowth. The incidence of possible complications related to stent coverage, namely, migration, pancreatitis, and cholecystitis, was lower than in previously published series.

Cited by 18 publications

References 22 publications

A prospective, multicenter study of a double stent system for palliative treatment of malignant extrahepatic biliary obstructions

A prospective, multicenter study of a double stent system for palliative treatment of malignant extrahepatic biliary obstructions

Endoscopic management of malignant biliary stenosis. Update and highlights for standard clinical practice

Percutaneous transhepatic hybrid biliary endoprostheses using both plastic and metallic stents for palliative treatment of malignant common bile duct obstruction

Contact Info

Product

Resources

About